{"altmetric_id":1991071,"counts":{"readers":{"mendeley":13,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["BTumour_fighter"],"posts_count":1}},"citation":{"abstract":"Chordomas are slow-growing tumors and most commonly involve the sacrum and clivus. Multiple recurrences are frequent. Childhood chordomas are rare and often show exceptionally aggressive behavior, resulting in short survival and a high incidence of metastatic spread.","abstract_source":"pubmed","altmetric_jid":"4f6fa62f3cf058f61000828a","authors":["Mohammed Faruq"],"doi":"10.1093\/neuonc\/not228","first_seen_on":"2013-12-19T03:38:35+00:00","issns":["1523-5866"],"journal":"Neuro-Oncology","last_mentioned_on":1387424309,"links":["http:\/\/neuro-oncology.oxfordjournals.org\/content\/early\/2013\/12\/17\/neuonc.not228.short?rss=1"],"pdf_url":"http:\/\/neuro-oncology.oxfordjournals.org\/content\/early\/2013\/12\/17\/neuonc.not228.full.pdf","pmid":"24305715","pubdate":"2013-01-01T00:00:00+00:00","publisher_subjects":[{"name":"Neurosciences","scheme":"era"},{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms","neurology"],"title":"Prognostic value of MIB-1, p53, epidermal growth factor receptor, and INI1 in childhood chordomas","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/prognostic-value-mib1-p53-epidermal-growth-factor-receptor-ini1-childhood-chordomas"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":4508612,"mean":5.1916753366762,"rank":3036585,"this_scored_higher_than_pct":20,"this_scored_higher_than":908707,"rank_type":"exact","sample_size":4508612,"percentile":20},"similar_age_3m":{"total_number_of_other_articles":119705,"mean":7.6355740660298,"rank":78004,"this_scored_higher_than_pct":20,"this_scored_higher_than":24490,"rank_type":"exact","sample_size":119705,"percentile":20},"this_journal":{"total_number_of_other_articles":978,"mean":2.2890665301945,"rank":591,"this_scored_higher_than_pct":9,"this_scored_higher_than":94,"rank_type":"exact","sample_size":978,"percentile":9},"similar_age_this_journal_3m":{"total_number_of_other_articles":18,"mean":5.0111764705882,"rank":13,"this_scored_higher_than_pct":11,"this_scored_higher_than":2,"rank_type":"exact","sample_size":18,"percentile":11}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Professor > Associate Professor":2,"Student  > Doctoral Student":1,"Researcher":2,"Student  > Ph. D. Student":2,"Other":1,"Student  > Master":1,"Student  > Bachelor":2,"Professor":2},"by_discipline":{"Medicine and Dentistry":8,"Neuroscience":1,"Agricultural and Biological Sciences":4}}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/BTumour_fighter\/status\/413513641808637952","license":"public","citation_ids":[1991071],"posted_on":"2013-12-19T03:38:29+00:00","author":{"name":"Ale C.","image":"https:\/\/pbs.twimg.com\/profile_images\/456317179055460352\/ZeLNx979_normal.jpeg","description":"Dx: Astrocytoma grade II (1997). After 17 years I'm still here, fighting my disease like the very 1st day. Sharing info about #BrainTumour . Welcome! :)","id_on_source":"BTumour_fighter","tweeter_id":"377932657","geo":{"lt":null,"ln":null},"followers":537},"tweet_id":"413513641808637952"}]}}